|
- 340B Drug Pricing Program | HRSA
The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services Manufacturers participating in Medicaid agree to provide outpatient drugs to covered entities at significantly reduced prices
- 340B Drug Pricing Program - Wikipedia
The 340B Drug Pricing Program is a U S federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices
- Fact Sheet: The 340B Drug Pricing Program - AHA
Major shifts to the 340B drug pricing program could be on the horizon, along with new regulations, legal battles and congressional scrutiny
- 340B Drug Pricing Program: How It Works, Why It’s Controversial . . .
Enacted in 1992, the 340B Drug Pricing Program requires drug manufacturers to provide significant price discounts on outpatient drugs purchased by certain federal government grantees
- Detailed Overview - 340B Health
Section 340B requires pharmaceutical manufacturers to enter into an agreement, called a pharmaceutical pricing agreement (PPA), with the HHS Secretary in exchange for having their drugs covered by Medicaid and Medicare Part B
- The 340B Rebate Pilot - mossadams. com
See how to prepare your organization for HRSA’s 340B Rebate Pilot program that shifts up-front discounts for nine key drugs to post-purchase rebates
- The Current Legal Landscape of the 340B Drug Pricing Program
The federal 340B Drug Pricing Program ("340B Program") was created by Congress in 1992 through an amendment to the Public Health Service Act [i] The program, which is administered by the Health Resources Services Administration ("HRSA"), was intended to enable certain hospitals and clinics "to stretch scarce federal resources as far as possible, reaching more eligible patients and providing
- 340B for Beginners
HRSA’s official 340B Prime Vendor, offering support, education, and tools to covered entities Provides discounted pricing beyond 340B through the Prime Vendor Program (PVP) Serves as a key resource for compliance guidance, training, and policy clarification
|
|
|